Prevalence of HIV and Disease Outcomes on the Medical and Surgical Wards at Kamuzu Central Hospital, Lilongwe, Malawi

Kendig, Claire E.; McCulloch, Denise J.; Rosenberg, Nora E.; Samuel, Jonathan C.; Mabedi, Charles; Shores, Carol G.; Hosseinipour, Mina C.; Matoga, Mitch; Charles, Anthony G.
October 2013
Tropical Medicine & Health;2013, Vol. 41 Issue 4, p163
Academic Journal
Introduction: (WHO) recommends HIV Counseling and Testing (HCT) in a range of clinical settings. We describe the characteristics of patients diagnosed with HIV on the medical and surgical wards at a tertiary care hospital in Malawi. Methods: Under the universal opt-out HCT protocol we characterized the number of new HIV/AIDS infections and associated clinical features among hospitalized surgical and medical patients diagnosed during the course of admission. Results: All 2985 and 3959 medical and surgical patients, respectively, admitted between April 2012 and January 2013 were screened for HCT. 62% and 89% of medical and surgical patients, respectively, had an unknown status on admission and qualified for testing. Of the patients with an unknown status, a new HIV diagnosis was made in 20% and 7% of medical and surgical patients, respectively. Of the newly diagnosed patients with a CD4 count recorded, 91% and 67% of medical and surgical patients, respectively, had a count less than 350, qualifying for ART by Malawi ART guidelines. Newly HIV-diagnosed medical and surgical patients had an inpatient mortality of 20% and 2%, respectively. Discussion: While newly diagnosed HIV-positive medical patients had high inpatient mortality and higher rates of WHO stage 3 or 4 conditions, surgical patients presented with less advanced HIV, though still meeting ART initiation guidelines. The medical inpatient wards are an obvious choice for implementing voluntary counseling and testing (VCT), but surgical patients present with less advanced disease and starting treatment in this group could result in more years of life gained.


Related Articles

  • Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1.  // Annals of Internal Medicine;10/7/2014, Vol. 161 Issue 7, pI-22 

    The article presents questions and answers related to HIV-1 treatment including how was study done, researchers findings and limitations of the study.

  • Reduction of Maternal Mortality with Highly Active Antiretroviral Therapy in a Large Cohort of HIV-Infected Pregnant Women in Malawi and Mozambique. Liotta, Giuseppe; Mancinelli, Sandro; Nielsen-Saines, Karin; Gennaro, E.; Scarcella, Paola; Magid, Nurja Abdul; Germano, Paola; Jere, Haswell; Guidotti, Gianni; Buonomo, Ersilia; Ciccacci, Fausto; Palombi, Leonardo; Marazzi, Maria Cristina // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background: HIV infection is a major contributor to maternal mortality in resource-limited settings. The Drug Resource Enhancement Against AIDS and Malnutrition Programme has been promoting HAART use during pregnancy and postpartum for Prevention-of-mother-to-child-HIV transmission (PMTCT)...

  • Sequence Conservation, HLA-E-Restricted Peptide, and Best-Defined CTL/CD8+ Epitopes in Gag P24 (Capsid) of HIV-1 Subtype B. Prasetyo, Afiono Agung; Dharmawan, Ruben; Sari, Yulia; Sariyatun, Ratna // AIP Conference Proceedings;2017, Vol. 1813 Issue 1, p1 

    Human immunodeficiency virus type 1 (HIV-1) remains a cause of global health problem. Continuous studies of HIV-1 genetic and immunological profiles are important to find strategies against the virus. This study aimed to conduct analysis of sequence conservation, HLA-E-restricted peptide, and...

  • Comment on "Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa". Fontaine, Christopher; Mahy, Mary; Izazola, José-Antonio; Ghys, Peter D. // Science Translational Medicine;8/2/2017, Vol. 9 Issue 401, p1 

    No abstract available.

  • Modeling secondary level of HIV contact tracing: its impact on HIV intervention in Cuba. Ying-Hen Hsieh; Yun-Shih Wang; de Arazoza, Hector; Lounes, Rachid // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p194 

    Background: Universal HIV testing/treatment program has currently been suggested and debated as a useful strategy for elimination of HIV epidemic in Africa, although not without practical issues regarding the costs and feasibility of a fully implemented program. Methods: A mathematical model is...

  • Clinical Implications of Identifying Non-B Subtypes of Human Immunodeficiency Virus Type 1... Walter, Elizabeth A.; Gilliam, Bruce; Delmar, Judy A.; Spooner, Katherine; Morris, Joseph T.; Aronson, Naomi; Wegner, Scott A.; Michael, Nelson L.; Jagodzinski, Linda L. // Clinical Infectious Diseases;9/1/2000, Vol. 31 Issue 3, p798 

    Presents the clinical implications of identifying non-B subtypes of HIV-type 1 infection. Identification of non-B subtypes of HIV-type 1 based on the low or undetected viral load; Heterogeneity among HIV-type 1 isolates; Three major phylogenetic groups of HIV; Prevalence and geographic...

  • Optimal Diagnostic Tests in Primary HIV-1 Infection. Sadovsky, Richard // American Family Physician;9/15/2001, Vol. 64 Issue 6, p1091 

    Presents an abstract of the study `Diagnosis of Primary HIV-1 Infection,' by E.S Daar et al., from the January 2, 2001 issue of the `Annals of Internal Medicine.'

  • Optimizing tuberculosis control in the inner city. FitzGerald, J. Mark // CMAJ: Canadian Medical Association Journal;3/23/99, Vol. 160 Issue 6, p821 

    Editorial. Discusses the control of tuberculosis (TB). The key principle in TB control; Reference to the paper by Dr. Wendy Wobeser and colleagues, in the this issue (page 789); Mention of New York City, New York results regarding HIV infected peoples and TB being a sign of infection of the...

  • Tests for infection with HIV: slandered goods. Mortimer, Philip P. // British Medical Journal (Clinical Research Edition);6/11/1988, Vol. 296 Issue 6637, p1615 

    Examines the accuracy of serological diagnosis for HIV infection in Africa. Availability of the tests; Characterization of courses for HIV infection;Development of antigenemia during the time between HIV exposure and antibody response.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics